• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Data Analytics Stocks Q1 Teardown: Health Catalyst (NASDAQ:HCAT) Vs The Rest

By: StockStory
June 16, 2025 at 23:37 PM EDT

HCAT Cover Image

As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the data analytics industry, including Health Catalyst (NASDAQ: HCAT) and its peers.

Organizations generate a lot of data that is stored in silos, often in incompatible formats, making it slow and costly to extract actionable insights, which in turn drives demand for modern cloud-based data analysis platforms that can efficiently analyze the siloed data.

The 5 data analytics stocks we track reported a strong Q1. As a group, revenues beat analysts’ consensus estimates by 2.1% while next quarter’s revenue guidance was in line.

Luckily, data analytics stocks have performed well with share prices up 15.9% on average since the latest earnings results.

Slowest Q1: Health Catalyst (NASDAQ: HCAT)

Founded by healthcare professionals Tom Burton and Steve Barlow in 2008, Health Catalyst (NASDAQ: HCAT) provides data and analytics technology to healthcare organizations, enabling them to improve care and lower costs.

Health Catalyst reported revenues of $79.41 million, up 6.3% year on year. This print was in line with analysts’ expectations, and overall, it was a satisfactory quarter for the company with a solid beat of analysts’ EBITDA estimates.

“For the first quarter of 2025, I am pleased by our strong financial results, including total revenue of $79.4 million and Adjusted EBITDA of $6.3 million, with these results beating our quarterly guidance on each metric,” said Dan Burton, CEO of Health Catalyst.

Health Catalyst Total Revenue

Health Catalyst delivered the weakest performance against analyst estimates and weakest full-year guidance update of the whole group. Unsurprisingly, the stock is down 5.5% since reporting and currently trades at $3.76.

Is now the time to buy Health Catalyst? Access our full analysis of the earnings results here, it’s free.

Best Q1: Domo (NASDAQ: DOMO)

Founded by Josh James after selling his former business Omniture to Adobe, Domo (NASDAQ: DOMO) provides business intelligence software that allows managers to access and visualize critical business metrics in real-time, using their smartphones.

Domo reported revenues of $80.11 million, flat year on year, outperforming analysts’ expectations by 3.1%. The business had a very strong quarter with EPS guidance for next quarter exceeding analysts’ expectations and a solid beat of analysts’ EBITDA estimates.

Domo Total Revenue

The market seems happy with the results as the stock is up 60.4% since reporting. It currently trades at $13.71.

Is now the time to buy Domo? Access our full analysis of the earnings results here, it’s free.

Amplitude (NASDAQ: AMPL)

Born out of a failed voice recognition startup by founder Spenser Skates, Amplitude (NASDAQ: AMPL) is data analytics software helping companies improve and optimize their digital products.

Amplitude reported revenues of $79.95 million, up 10.1% year on year, in line with analysts’ expectations. Still, its results were good as it locked in an impressive beat of analysts’ billings estimates and a solid beat of analysts’ EBITDA estimates.

Interestingly, the stock is up 28.3% since the results and currently trades at $12.06.

Read our full analysis of Amplitude’s results here.

Palantir (NASDAQ: PLTR)

Started by Peter Thiel after seeing US defence agencies struggle in the aftermath of the 2001 terrorist attacks, Palantir (NYSE: PLTR) offers software as a service platform that helps government agencies and large enterprises use data to make better decisions.

Palantir reported revenues of $883.9 million, up 39.3% year on year. This print beat analysts’ expectations by 2.5%. It was a very strong quarter as it also logged a solid beat of analysts’ billings estimates and an impressive beat of analysts’ EBITDA estimates.

Palantir pulled off the fastest revenue growth and highest full-year guidance raise among its peers. The stock is up 13.9% since reporting and currently trades at $141.21.

Read our full, actionable report on Palantir here, it’s free.

Samsara (NYSE: IOT)

One of the few public companies where famed investor Marc Andreessen is a Board member, Samsara (NYSE: IOT) provides software and hardware to track industrial equipment, assets, and fleets.

Samsara reported revenues of $366.9 million, up 30.7% year on year. This number topped analysts’ expectations by 4.4%. Overall, it was a very strong quarter as it also produced EPS guidance for next quarter exceeding analysts’ expectations and a solid beat of analysts’ EBITDA estimates.

Samsara delivered the biggest analyst estimates beat among its peers. The company added 132 enterprise customers paying more than $100,000 annually to reach a total of 2,638. The stock is down 17.6% since reporting and currently trades at $39.

Read our full, actionable report on Samsara here, it’s free.

Market Update

Thanks to the Fed’s rate hikes in 2022 and 2023, inflation has been on a steady path downward, easing back toward that 2% sweet spot. Fortunately (miraculously to some), all this tightening didn’t send the economy tumbling into a recession, so here we are, cautiously celebrating a soft landing. The cherry on top? Recent rate cuts (half a point in September 2024, a quarter in November) have propped up markets, especially after Trump’s November win lit a fire under major indices and sent them to all-time highs. However, there’s still plenty to ponder — tariffs, corporate tax cuts, and what 2025 might hold for the economy.

Want to invest in winners with rock-solid fundamentals? Check out our 9 Best Market-Beating Stocks and add them to your watchlist. These companies are poised for growth regardless of the political or macroeconomic climate.

More News

View More
Insiders Trade Millions in NVIDIA-Linked Navitas, Hims, & Shift4
August 18, 2025
Via MarketBeat
Topics Artificial Intelligence
Tickers FOUR HIMS NVDA NVO NVTS
Why Datadog Is the AI Infrastructure Firm to Watch Out For
August 18, 2025
Via MarketBeat
Topics Artificial Intelligence
Tickers DDOG
4 Stocks Every AI ETF Is Buying—And They’re Not What You Think
August 18, 2025
Via MarketBeat
Topics Artificial Intelligence ETFs
Tickers AIQ ALAB IGPT IVZ ORCL SNOW
Grab Holdings: Get a Grip Now—Explosive Upside Brewing
August 18, 2025
Via MarketBeat
Tickers GRAB
Rocket Stock Just Broke Out, But EPS Growth Still Isn't Priced In
August 18, 2025
Via MarketBeat
Tickers RKT
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap